| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004550 | American Journal of Ophthalmology | 2008 | 7 Pages |
Abstract
These data suggest that bimatoprost is an effective IOP-lowering agent in patients with uveitic glaucoma in whom the uveitis is controlled on immunomodulatory therapy, and it does not increase the rate of flares of uveitis in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Egidio Fortuna, Rene A. Castañeda-Cervantes, Pooja Bhat, Priyanka Doctor, C. Stephen Foster,